4,4-DIFLUORO-N-((1S)-3-((1R,5S)-3-(3-(HYDROXYMETHYL)-5-ISOPROPYL-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO(3.2.1)OCTAN-8-YL)-1-PHENYL-PROPYL)CYCLOHEXANECARBOXAMIDE
UNII MD6TSO240K
Substance Identification & Data
This profile provides standardized clinical and technical data for 4,4-difluoro-n-((1s)-3-((1r,5s)-3-(3-(hydroxymethyl)-5-isopropyl-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)octan-8-yl)-1-phenyl-propyl)cyclohexanecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MD6TSO240K.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2230267-78-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H41F2N5O2 QYAXWUVUSZZECX-NDBXHCKUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4,4-difluoro-n-((1s)-3-((1r,5s)-3-(3-(hydroxymethyl)-5-isopropyl-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)octan-8-yl)-1-phenyl-propyl)cyclohexanecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.